Royal Bank of Canada’s Imago BioSciences, Inc. Common stock IMGO Stock Holding History

Royal Bank of Canada’s Portfolio IMGO Stock Details IMGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-3,428	Closed	-$123K	–	7845
2022 Q4	$123K	Buy	3,428 +3,108	+971%	+$77.7K	﹤0.01%	5299
2022 Q3	$5K	Buy	320 +172	+116%	+$2.79K	﹤0.01%	6778
2022 Q2	$2K	Sell	148 -1,085	-88%	-$17.2K	﹤0.01%	7044
2022 Q1	$24K	Sell	1,233 -677	-35%	-$14K	﹤0.01%	6527
2021 Q4	$46K	Buy	1,910 +822	+76%	+$19K	﹤0.01%	6423
2021 Q3	$21K	Buy	+1,088	New	+$23.3K	﹤0.01%	6694

Royal Bank of Canada's IMGO Position: Q1 2023 in Review

Royal Bank of Canada sold out of Imago BioSciences, Inc. Common stock (IMGO) in Q1 2023, closing a stake of 3,428 shares — an estimated $123K sold.

Royal Bank of Canada first reported a position in IMGO in Q3 2021 and held it in 6 quarters. The position peaked at $123K in Q4 2022. 0 funds tracked by Wall St. Rank hold IMGO as of Q1 2023.

Royal Bank of Canada reported no remaining Imago BioSciences, Inc. Common stock position as of Q1 2023 after selling out during the quarter.
Royal Bank of Canada sold 3,428 Imago BioSciences, Inc. Common stock shares in Q1 2023, an estimated $123K.
Royal Bank of Canada first reported a position in Imago BioSciences, Inc. Common stock in Q3 2021 and held it in 6 quarters.
Royal Bank of Canada's Imago BioSciences, Inc. Common stock position peaked at $123K in Q4 2022.
0 funds tracked by Wall St. Rank held Imago BioSciences, Inc. Common stock as of Q1 2023.

Based on Royal Bank of Canada's 13F filing for Q1 2023, filed 15 May 2023.